首页    期刊浏览 2025年07月18日 星期五
登录注册

文章基本信息

  • 标题:Pandemic, Patents and Public Health
  • 本地全文:下载
  • 作者:Manchikanti, Padmavati ; Dias, Michelle
  • 期刊名称:Journal of Intellectual Property Rights
  • 印刷版ISSN:0971-7544
  • 电子版ISSN:0975-1076
  • 出版年度:2021
  • 卷号:26
  • 期号:4
  • 页码:187-198
  • 语种:English
  • 出版社:Ubs Publishers Distributors
  • 摘要:The COVID-19 pandemic has compelled a relook at public healthcare and the patent systems. It has brought to haltlivelihoods with devastating consequences to people’s lives national economies. Global health security is at stake as there isa need to develop and deploy more vaccines, repurpose medicines and increase medical infrastructure support. Collaborationand collective response is imperative at international and national levels. IPR access is crucial in relation to public health.Many countries have issued new policies and enacted laws to make it easier for them to supply medicines to their populationduring the pandemic. Compulsory licensing has been used as an important mechanism to open up IP without the permissionof patent holders. The present study analyses amendments to patent law and IP legislations that are effected from a crosscountry perspective during the pandemic time. It also examines international cooperation in the context of public health andIP under the TRIPS Agreement in view of the on-going consultation at the WTO. The study reveals differences inapproaches to ‘governmental use’ of patents and access to know-how under the statutory framework. Improving the scope ofuse of products and process patents, suspension of patent term extension, consolidating the compulsory licensingmechanism, removal of inequity are the predominant aspects that are part of the amendments to patent law in the countries.Pandemics like COVID-19 need legislative initiatives to secure healthcare system access for all citizens. Healthcareaccess includes ready availability of basic vaccines, drugs, medical devices and medical infrastructure. There is often a clashbetween access to healthcare as a fundamental right on one hand and the need to award monopolies in the form of IP rightsas an incentive for innovations from the pharmaceutical industry on the other. Hence, obstacles arise in decision-making tobalance innovation incentives and ensuring rights to access healthcare. Judicial decision-making and public policy-makinghave been always at the centre stage in earlier epidemics and now in the current pandemic making it imperative for countriesto protect the health interests of their citizens.
  • 关键词:Pandemic; Covid-19; Public Health; Compulsory Licensing; TRIPS Agreement; Patents; Article
国家哲学社会科学文献中心版权所有